News | January 18, 2010

Court Dismisses ACC Suit Opposing Reimbursement Cuts

Jack Lewin, M.D., ACC CEO

January 18, 2010 – A federal judge dismissed a lawsuit filed by the American College of Cardiology (ACC) against the Department of Health and Human Services (HHS) to prevent drastic reimbursement cuts. The reduction in payments began Jan. 1.

In the suit filed in December, the ACC accused the HHS of violating federal Medicare laws when it based payment reductions for some cardiology services on flawed data. Some cuts are as high as 40 percent. The ACC asked the U.S. District Court for the Southern District of Florida to prevent Centers for Medicare and Medicaid Services (CMS) from making the cuts. However, Judge William Dimitrouleas denied the ACC’s motions Jan. 12.

“We are deeply disappointed in the judge’s decision not to hear our case based on his opinion that the federal courts do not have jurisdiction to review Medicare physician payment determinations,” said Jack Lewin, M.D., ACC CEO. “What is deeply troubling about today’s ruling is that it sets the precedent that CMS has complete and unchecked control over physician reimbursement for patient care even where its determinations are based on faulty data.”

The 2010 fee schedule from CMS revised the reimbursements for several specialty services, including cardiology. The ACC said the significant pay cuts threaten to harm patients’ access to care.

Lewin said ironically, this rule may increase Medicare costs by shifting cardiologists and their patients to more expensive hospital settings.

Lewin said the ACC is pursuing Congressional legislation and is speaking with legislators about the cuts and the potential issues they may cause in the patient’s access to healthcare.

“Our ongoing campaign for patient access is about making quality cardiovascular care accessible to the millions of Americans who are battling our country’s number one killer, heart disease,” Lewin said. “We will continue to fight on behalf of our patients to protect their access to quality care.”

For more information: www.campaignforpatientaccess.org

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init